Antileukotriene drugs in the treatment of asthma
- PMID:20332717
Antileukotriene drugs in the treatment of asthma
Abstract
Antileukotriene medications that have been implemented into clinical practice of bronchial asthma and allergic rhinitis include specific leukotriene receptor antagonists (montelukast, zafirlukast, pranlukast) and leukotriene biosynthesis inhibitors (zileuton). The current GINA (Global Initiative for Asthma) guidelines, the PRACTALL (Practicing Allergology) report on asthma treatment in children, and ARIA (Allergic Rhinitis and its Impact on Asthma) recommendations classify antileukotriene therapeutic agents as a group of drugs controlling the course of the disease. However, inhaled glucocorticosteroids still remain the first-line treatment in chronic asthma. According to current guidelines, antileukotriene drugs are recommended as alternative treatment to low-dose inhaled glucocorticosteroids in the second level of asthma severity and as complementary treatment to inhaled and/or oral glucocorticosteroids, starting from the third level of asthma severity. Recently, clinical efficacy of antileukotriene drugs has been suggested in the treatment of isolated allergic rhinitis, chronic cough in the course of asthma, as a sole symptom of the disease, and as the therapy for episodes of wheezing caused by viral infections.
Similar articles
- [Antileukotriene drugs in the treatment of obstructive lung diseases and rhinitis].Mastalerz L, Kania A.Mastalerz L, et al.Pneumonol Alergol Pol. 2010;78(1):74-8.Pneumonol Alergol Pol. 2010.PMID:20162522Review.Polish.
- Use of leukotriene antagonists in childhood asthma.Krawiec ME, Wenzel SE.Krawiec ME, et al.Curr Opin Pediatr. 1999 Dec;11(6):540-7. doi: 10.1097/00008480-199912000-00012.Curr Opin Pediatr. 1999.PMID:10590913Review.
- Advances in therapy with antileukotriene drugs.Riccioni G, Di Ilio C, Conti P, Theoharides TC, D'Orazio N.Riccioni G, et al.Ann Clin Lab Sci. 2004 Autumn;34(4):379-87.Ann Clin Lab Sci. 2004.PMID:15648777Review.
- Montelukast in guidelines and beyond.Bousquet J, Demoly P, Humbert M.Bousquet J, et al.Adv Ther. 2009 Jun;26(6):575-87. doi: 10.1007/s12325-009-0038-1. Epub 2009 Jun 26.Adv Ther. 2009.PMID:19562275Review.
- Effectiveness of montelukast in the treatment of cough variant asthma.Spector SL, Tan RA.Spector SL, et al.Ann Allergy Asthma Immunol. 2004 Sep;93(3):232-6. doi: 10.1016/S1081-1206(10)61493-7.Ann Allergy Asthma Immunol. 2004.PMID:15478381Clinical Trial.
Cited by
- Antileukotrienes for the prevention and treatment of chronic lung disease in very preterm newborns: a systematic review.Jukema M, Borys F, Sibrecht G, Jørgensen KJ, Bruschettini M.Jukema M, et al.Respir Res. 2021 Jul 17;22(1):208. doi: 10.1186/s12931-021-01800-1.Respir Res. 2021.PMID:34273977Free PMC article.
- The effects of zileuton and montelukast in reperfusion-induced arrhythmias in anesthetized rats.Gonca E.Gonca E.Curr Ther Res Clin Exp. 2013 Dec;75:27-32. doi: 10.1016/j.curtheres.2013.06.001.Curr Ther Res Clin Exp. 2013.PMID:24465039Free PMC article.
- Structure based virtual screening of ligands to identify cysteinyl leukotriene receptor 1 antagonist.Bandaru S, Marri VK, Kasera P, Kovuri P, Girdhar A, Mittal DR, Ikram S, Gv R, Nayarisseri A.Bandaru S, et al.Bioinformation. 2014 Oct 30;10(10):652-7. doi: 10.6026/97320630010652. eCollection 2014.Bioinformation. 2014.PMID:25489175Free PMC article.
- Therapeutic options for severe asthma.Mathew J, Aronow WS, Chandy D.Mathew J, et al.Arch Med Sci. 2012 Sep 8;8(4):589-97. doi: 10.5114/aoms.2012.30280.Arch Med Sci. 2012.PMID:23056066Free PMC article.
- Silicone breast implant modification review: overcoming capsular contracture.Shin BH, Kim BH, Kim S, Lee K, Choy YB, Heo CY.Shin BH, et al.Biomater Res. 2018 Dec 20;22:37. doi: 10.1186/s40824-018-0147-5. eCollection 2018.Biomater Res. 2018.PMID:30598837Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical